EMA — authorised 4 January 2017
- Marketing authorisation holder: CSL Behring GmbH
- Status: approved
🇪🇺 Afstyla in European Union
EMA authorised Afstyla on 4 January 2017
Marketing authorisation
Afstyla in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in European Union
Frequently asked questions
Is Afstyla approved in European Union?
Yes. EMA authorised it on 4 January 2017.
Who is the marketing authorisation holder for Afstyla in European Union?
CSL Behring GmbH holds the EU marketing authorisation.